This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Luke Heuer, Ph.D.
Postdoctoral Researcher at University of California, Davis
Speaker

Profile

Dr. Luke Heuer received his PhD in Immunology from UC Davis in 2011 with a focus on autoimmunity. Dr. Heuer’s postdoctoral experience has ranged from, the EAE model of multiple sclerosis, to autoantibody production in Autism as a Hartwell Foundation Fellow, to animal models of Type 1 Diabetes and Primary Biliary Cholangitis. In 2021, Dr. Heuer was promoted to Project Scientist at University of California, Davis. He works with Dr. William Ridgway and currently focuses on developing immune based therapies for autoimmune disease.

Agenda Sessions

  • Higher Order Receptor Clustering Due to the IgG3 Subclass is Necessary for TLR4 Signaling and Tolerance Induction by Novel Human anti-TLR4 Antibodies

    3:15pm